Literature DB >> 33469864

Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism.

Xin Zhang1,2, Can Hu1,2, Yu-Pei Yuan1,2, Peng Song1,2, Chun-Yan Kong1,2, Hai-Ming Wu1,2, Si-Chi Xu1,2, Zhen-Guo Ma3,4, Qi-Zhu Tang5,6.   

Abstract

Cardiac endothelium communicates closely with adjacent cardiac cells by multiple cytokines and plays critical roles in regulating fibroblasts proliferation, activation, and collagen synthesis during cardiac fibrosis. E26 transformation-specific (ETS)-related gene (ERG) belongs to the ETS transcriptional factor family and is required for endothelial cells (ECs) homeostasis and cardiac development. This study aims at investigating the potential role and molecular basis of ERG in fibrotic remodeling within the adult heart. We observed that ERG was abundant in murine hearts, especially in cardiac ECs, but decreased during cardiac fibrosis. ERG knockdown within murine hearts caused spontaneously cardiac fibrosis and dysfunction, accompanied by the activation of multiple Smad-dependent and independent pathways. However, the direct silence of ERG in cardiac fibroblasts did not affect the expression of fibrotic markers. Intriguingly, ERG knockdown in human umbilical vein endothelial cells (HUVECs) promoted the secretion of endothelin-1 (ET-1), which subsequently accelerated the proliferation, phenotypic transition, and collagen synthesis of cardiac fibroblasts in a paracrine manner. Suppressing ET-1 with either a neutralizing antibody or a receptor blocker abolished ERG knockdown-mediated deleterious effect in vivo and in vitro. This pro-fibrotic effect was also negated by RGD (Arg-Gly-Asp)-peptide magnetic nanoparticles target delivery of ET-1 small interfering RNA to ECs in mice. More importantly, we proved that endothelial ERG overexpression notably prevented pressure overload-induced cardiac fibrosis. Collectively, endothelial ERG alleviates cardiac fibrosis via blocking ET-1-dependent paracrine mechanism and it functions as a candidate for treating cardiac fibrosis. • ERG is abundant in murine hearts, especially in cardiac ECs, but decreased during fibrotic remodeling. • ERG knockdown causes spontaneously cardiac fibrosis and dysfunction. • ERG silence in HUVECs promotes the secretion of endothelin-1, which in turn activates cardiac fibroblasts in a paracrine manner. • Endothelial ERG overexpression prevents pressure overload-induced cardiac fibrosis.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature.

Entities:  

Keywords:  ERG; Endothelial cells; Endothelin-1; Fibroblasts; Paracrine

Mesh:

Substances:

Year:  2021        PMID: 33469864     DOI: 10.1007/s10565-021-09581-5

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  74 in total

Review 1.  Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives.

Authors:  Arantxa González; Erik B Schelbert; Javier Díez; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2018-04-17       Impact factor: 24.094

2.  New human erg isoforms generated by alternative splicing are transcriptional activators.

Authors:  M Duterque-Coquillaud; C Niel; S Plaza; D Stehelin
Journal:  Oncogene       Date:  1993-07       Impact factor: 9.867

3.  Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes.

Authors:  Claudia D Baldus; Sandya Liyanarachchi; Krzysztof Mrózek; Herbert Auer; Stephan M Tanner; Martin Guimond; Amy S Ruppert; Nehad Mohamed; Ramana V Davuluri; Michael A Caligiuri; Clara D Bloomfield; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-08       Impact factor: 11.205

4.  Endothelial cell induced modulation of cardiac fibroblast collagen metabolism.

Authors:  E Guarda; P R Myers; C G Brilla; S C Tyagi; K T Weber
Journal:  Cardiovasc Res       Date:  1993-06       Impact factor: 10.787

5.  Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin.

Authors:  Graeme M Birdsey; Nicola H Dryden; Valerie Amsellem; Frank Gebhardt; Kapil Sahnan; Dorian O Haskard; Elisabetta Dejana; Justin C Mason; Anna M Randi
Journal:  Blood       Date:  2008-01-14       Impact factor: 22.113

Review 6.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

Authors:  Rik Derynck; Ying E Zhang
Journal:  Nature       Date:  2003-10-09       Impact factor: 49.962

Review 7.  Endothelins in cardiovascular biology and therapeutics.

Authors:  Neeraj Dhaun; David J Webb
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

Review 8.  Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.

Authors:  Robert G Gourdie; Stefanie Dimmeler; Peter Kohl
Journal:  Nat Rev Drug Discov       Date:  2016-06-24       Impact factor: 84.694

9.  Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression.

Authors:  Michael Ginsberg; Daylon James; Bi-Sen Ding; Daniel Nolan; Fuqiang Geng; Jason M Butler; William Schachterle; Venkat R Pulijaal; Susan Mathew; Stephen T Chasen; Jenny Xiang; Zev Rosenwaks; Koji Shido; Olivier Elemento; Sina Y Rabbany; Shahin Rafii
Journal:  Cell       Date:  2012-10-18       Impact factor: 41.582

10.  Dynamic regulation of canonical TGFβ signalling by endothelial transcription factor ERG protects from liver fibrogenesis.

Authors:  Neil P Dufton; Claire R Peghaire; Lourdes Osuna-Almagro; Claudio Raimondi; Viktoria Kalna; Abhishek Chauhan; Gwilym Webb; Youwen Yang; Graeme M Birdsey; Patricia Lalor; Justin C Mason; David H Adams; Anna M Randi
Journal:  Nat Commun       Date:  2017-10-12       Impact factor: 14.919

View more
  16 in total

Review 1.  The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism.

Authors:  Yukang Mao; Kun Zhao; Peng Li; Yanhui Sheng
Journal:  Mol Cell Biochem       Date:  2022-10-10       Impact factor: 3.842

Review 2.  Diagnostic and Therapeutic Properties of Exosomes in Cardiac Fibrosis.

Authors:  Jiwen Fan; Meng Ren; Yuquan He
Journal:  Front Cell Dev Biol       Date:  2022-07-04

Review 3.  The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis.

Authors:  Jiwen Fan; Meng Ren; Binay Kumar Adhikari; Haodong Wang; Yuquan He
Journal:  J Inflamm Res       Date:  2022-07-07

4.  MicroRNA-495-3p diminishes doxorubicin-induced cardiotoxicity through activating AKT.

Authors:  Jun Meng; Can Xu
Journal:  J Cell Mol Med       Date:  2022-02-13       Impact factor: 5.310

5.  Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin.

Authors:  Zheng Tang; Wanli Jiang; Ming Mao; Jinping Zhao; Jiakuan Chen; Nitao Cheng
Journal:  Clin Transl Med       Date:  2021-04

6.  MicroRNA-23a-5p Is Involved in the Regulation of Lipopolysaccharide-Induced Acute Lung Injury by Targeting HSP20/ASK1.

Authors:  Yi-Fei Chen; Fen Hu; Xian-Guo Wang; Zheng Tang; He-Xiao Tang; Ming Xu
Journal:  Oxid Med Cell Longev       Date:  2021-08-11       Impact factor: 6.543

7.  Ubiquitin-Specific Protease 29 Exacerbates Cerebral Ischemia-Reperfusion Injury in Mice.

Authors:  Jia-Bao Hou; Qian-Ni Shen; Xing Wan; Xu-Ke Liu; Yuan Yu; Mei Li; Wen-Wei Gao; Bo Zhao
Journal:  Oxid Med Cell Longev       Date:  2021-11-16       Impact factor: 6.543

8.  Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice.

Authors:  Can Hu; Xin Zhang; Min Hu; Teng Teng; Yu-Pei Yuan; Peng Song; Chun-Yan Kong; Si-Chi Xu; Zhen-Guo Ma; Qi-Zhu Tang
Journal:  Aging Cell       Date:  2022-02-15       Impact factor: 9.304

9.  Pitavastatin maintains MAPK7 expression and alleviates angiotensin II-induced vascular endothelial cell inflammation and injury.

Authors:  Min Li; Xiaohua Liu
Journal:  Exp Ther Med       Date:  2021-12-13       Impact factor: 2.447

10.  HDAC11 promotes both NLRP3/caspase-1/GSDMD and caspase-3/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells.

Authors:  Jianli Gu; Rong Lin; Feng Yao; Zhen Jin; Zihan Zheng; Xiaohan Lv; Lingxuan Ren; Jianjun Yang; Danli Chen; Bo Wang; Wei Yang; Lifang Chen; Weirong Wang
Journal:  Cell Death Discov       Date:  2022-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.